Molecular Drivers of Oncotype DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study

The Oncotype DX Recurrence Score (RS), Prosigna Prediction Analysis of Microarray 50 (PAM50) Risk of Recurrence (ROR), EndoPredict (EP), and Breast Cancer Index (BCI) are used clinically for estimating risk of distant recurrence for patients receiving endocrine therapy. Discordances in estimates occ...

Descripción completa

Detalles Bibliográficos
Autores principales: Buus, Richard, Sestak, Ivana, Kronenwett, Ralf, Ferree, Sean, Schnabel, Catherine A., Baehner, Frederick L., Mallon, Elizabeth A., Cuzick, Jack, Dowsett, Mitch
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2021
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078458/
https://www.ncbi.nlm.nih.gov/pubmed/33108242
http://dx.doi.org/10.1200/JCO.20.00853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078458/
https://www.ncbi.nlm.nih.gov/pubmed/33108242
http://dx.doi.org/10.1200/JCO.20.00853

Ejemplares similares